ANI Pharmaceuticals reported $602.63M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AbbVie USD 27.68B 2.09B Mar/2025
ANI Pharmaceuticals USD 602.63M 66.34M Jun/2025
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Novartis USD 25.94B 3.76B Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Sun Pharmaceuticals INR 525.94B 64.89B Mar/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025